The 2023 SIUU Communication Draft Guidance (or “2023 Draft Guidance”) provides FDA’s interpretation of how unapproved uses of approved or cleared medical products can be communicated by firms in a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback